OGO. G. Grechishnikova

O. G. Grechishnikova

*This is an algorithmically generated author record based on publicly available information.

O. G. Grechishnikova has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serotypes, Clonality, and Virulence Gene Distribution in Streptococcus agalactiae Isolates recovered in Russian Federation in 2021–2024

    by E. A. Egorova, Y. N. Urban, A. L. Bayrakova, O. G. Grechishnikova, V. A. Kuzmenok, E. A. Voropaeva, E V. Rumiantseva, P. V. Mitkovets

    Background . Streptococcus agalactiae (Group B Streptococcus, GBS) remains a leading cause of severe perinatal infections. The key features of S. agalactiae population in Russia remain underexplored, necessitating comprehensive molecular surveillance. Aim . This study aimed to perform a comprehensive analysis of the serotype distribution, clonality, and prevalence of genetic virulence determinants in S. agalactiae isolates recovered in Russia in 2021–2024. Materials and Methods . We analysed 72 non-invasive S. agalactiae isolates. The isolates were collected in Northwestern Federal District between 2021 and 2024 from patients (30 males and 42 females, aged 18–55 years). We recovered the isolates from vaginal, cervical, and urethral swabs, urine, prostate secretion, and semen. We performed initial species identification by standard bacteriological methods, latex agglutination and PCR. The isolates were whole-genome sequenced. We used bioinformatic analysis to derive serotypes, multi-locus sequence types (ST), clonal complexes (CC) and virulence genes from genome data. Results and Discussion . Our data revealed that serotypes V (34.7 %), Ia (22.2%), and III (22.2 %) were predominant, collectively accounting for 79.1 % of the isolates. The isolates exhibited high genetic diversity, comprising 22 sequence types (STs) grouped into 7 clonal complexes (CCs). The dominant CCs were CC1 (29.2 %), CC23 (23.6 %), CC19 (19.4 %), and CC17 (12.5 %). The most prevalent pilus genotype was PI-1+PI-2a1 (36%). The genes encoding surface protein Srr1 and Alp-like proteins were detected in 80.6% and 58% of isolates, respectively. The isolated of hypervirulent CC17 complex carried hvgA, srr2, and rib genes. Conclusion . We found that the S. agalactiae isolates exhibited high genetic diversity, with predominant serotypes V, Ia, and III and clonal complexes CC1, CC23, CC19, and CC17. Our analysis revealed a prevalence (12.5%) of the hypervirulent CC17 clone, confirming the circulation of high-risk strains associated with neonatal invasive disease. Our results indicate that a hexavalent conjugate vaccine would likely cover a majority of the circulating strains. We identified specific virulence gene profiles and their association with certain clonal complexes. Our results suggest that the revealed virulence factors are promising targets for serotype-independent vaccine development.

  • The mutual influence of parasitosis and sensitization to house dust mites

    by A.P. Toptygina, Z.E. Afridonova, P.E. Zherdeva, O.G. Grechishnikova, M.A. Smerdova

  • Features of whooping cough in adolescents: clinical, diagnostic, and immunological aspects

    by Moscow Russian Medical Academy Of Continuous Professional Education, O.P. Popova, J.V. Shvetsova, Moscow Infectious Clinical Hospital No 1, S.V. Bunin, I.M. Fedorova, S.I. Koteleva, S.V. Trushakova, O.G. Grechishnikova, K.V. Zharikova

    Objective. To analyze the clinical, diagnostic, and immunological characteristics of pertussis in adolescents. Patients and methods. The analysis is based on observations of 90 adolescents hospitalized in 2023–2024 with a diagnosis of pertussis. In 64 (71.1%) children, pertussis was observed in combination with other respiratory diseases. To verify the primary diagnosis, polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA) methods were used; to diagnose acute respiratory viral infection, PCR was used, and for mycoplasma infection, the ELISA method was used. Immunological studies included assessment of lymphocyte subpopulation composition, interferon system, serum IgE content, and spectrum of antibodies against Bordetella pertussis. Results. Whooping cough in adolescents was characterized by a typical clinical symptom complex, but it was noteworthy that patients were admitted to the hospital mainly in the late stages of the disease: 60.4% of patients were hospitalized in the 5th week, 39.6% in the 4th week of the disease. At the same time, 83 (92.2%) patients had a moderate form of the disease, 5 (5.6%) had a severe form, and 2 (2.2%) had a mild form. The most characteristic immune status abnormalities were low NK cell (CD3–CD16+CD56+) counts, detected in 53.7% of patients. The CD4/CD8 ratio was below reference values in 58.5% of adolescents. Changes in the interferon system mainly affected the ability of lymphocytes to produce interferon-γ: low values were detected in 63.4% of patients. Conclusion. The analysis demonstrates that pertussis in adolescents typically manifests as moderate forms of the disease, with severe forms being recorded in recent years. Noteworthy are the prolonged prodromal period, the pronounced psychoemotional component of the whooping cough symptom complex, and the high frequency of mixed infections. Immunological studies have revealed changes in the cellular link and interferon system, as well as an increase in serum IgE in a significant number of patients. Key words: whooping cough, cough, adolescents, acute respiratry viral infections, lymphocyte subpopulations, interferon protection

  • Open Access

    Experience of using inhaled steroid therapy in children with whooping cough

    by O. P. Popova, Yu. V. Shvetsova, S. V. Bunin, I. M. Fedorova, S. I. Koteleva, O. G. Grechishnikova, Ю. В. Швецова

    The aim of study: аnalysis of the effectiveness of inhaled steroid therapy in patients with whooping cough.Materials and methods: 74 patients with whooping cough were observed, among whom 40 children included inhalations with Budesonide in complex therapy (main group). 34 patients in the comparison group received only basic therapy. The age structure in the main group was as follow: тhere were children under one years old 18 (47.4 ± 8.1%), 1—3 years — 7 (18.4 ± 6.3%); 4—6 years — 8 (21 ± 6.6%), 7—14 years — 7 (13.2 ± 5.5%) and comparable to the comparison group. To verify whooping cough were used the PCR method and serological diagnostic (IFA) using a test system “Ridascreen/Bordetella pertussis («R-biofarm AMG», Germany). Results: budеsonide was prescribed for a course of 5—7 days. Clinical analysis of dynamics of cough in main group showed, that a reduction in a number of attacks by the 4—5th day of budesonide was observed in majority of children (35/87.5 ± 5.2%). In the main group coughing attacks with a frequency of more than 15—25 times a day persisted for 2.7 ± 0.2 days, and in comparison group — 4.3 ± 0.2 (p < 0.001). Relief of broncho-obstructive syndrome was observed in shorter period of time, which contributes to a reduction in the average length of stay of the patient in the hospital.